Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Lilly designs selective 5-HT1A antagonists especially for nicotine/tobacco withdrawal

July 12, 1999

LecTec granted patents on cotinine for smoking cessation and psychiatric disorders

July 7, 1999

Orphan Medical's Antizol injection receives approval in the U.K.

June 29, 1999

Cantab's vaccine for cocaine addiction shows encouraging phase I results

June 18, 1999

M-100907: a potential treatment for coexisting cocaine dependence and schizophrenia

May 26, 1999

Systematic review of published studies questions efficacy of carbamazepine in cocaine dependency

May 26, 1999

Slow-release naltrexone enters the clinic

April 29, 1999

Nabi nicotine vaccine shows promise in preclinical studies

April 22, 1999

Immunization strategy effectively blocks the behavioral effects of cocaine in monkeys

April 22, 1999

U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction

April 9, 1999

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...